These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 9400775)

  • 61. Treatment outcomes in the tube versus trabeculectomy study after one year of follow-up.
    Gedde SJ; Schiffman JC; Feuer WJ; Herndon LW; Brandt JD; Budenz DL
    Am J Ophthalmol; 2007 Jan; 143(1):9-22. PubMed ID: 17083910
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Otago glaucoma surgery outcome study : long-term results of uveitis with secondary glaucoma drained by Molteno implants.
    Molteno AC; Sayawat N; Herbison P
    Ophthalmology; 2001 Mar; 108(3):605-13. PubMed ID: 11237917
    [TBL] [Abstract][Full Text] [Related]  

  • 63. A Retrospective Comparison of Primary Baerveldt Implantation versus Trabeculectomy with Mitomycin C.
    Panarelli JF; Banitt MR; Gedde SJ; Shi W; Schiffman JC; Feuer WJ
    Ophthalmology; 2016 Apr; 123(4):789-95. PubMed ID: 26746596
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Survival analysis for success of Molteno tube implants.
    Broadway DC; Iester M; Schulzer M; Douglas GR
    Br J Ophthalmol; 2001 Jun; 85(6):689-95. PubMed ID: 11371490
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Surgical results and complications of trabeculectomy with intraoperative application of mitomycin C.
    Matsuda T; Tanihara H; Hangai M; Chihara E; Honda Y
    Jpn J Ophthalmol; 1996; 40(4):526-32. PubMed ID: 9130057
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Primary trabeculectomy with mitomycin C: safety and efficacy at 2 years.
    Lusthaus JA; Kubay O; Karim R; Wechsler D; Booth F
    Clin Exp Ophthalmol; 2010 Dec; 38(9):831-8. PubMed ID: 20572827
    [TBL] [Abstract][Full Text] [Related]  

  • 67. E-PTFE (Gore-Tex) implant with or without low-dosage mitomycin-C as an adjuvant in penetrating glaucoma surgery: 2 year randomized clinical trial.
    Cillino S; Zeppa L; Di Pace F; Casuccio A; Morreale D; Bocchetta F; Lodato G
    Acta Ophthalmol; 2008 May; 86(3):314-21. PubMed ID: 17995980
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Otago Glaucoma Surgery Outcome Study: follow-up of young patients who underwent Molteno implant surgery.
    Ah-Chan JJ; Molteno AC; Bevin TH; Herbison P
    Ophthalmology; 2005 Dec; 112(12):2137-42. PubMed ID: 16325709
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Clinical results of Ahmed glaucoma valve implantation in refractory glaucoma with adjunctive mitomycin C.
    Kook MS; Yoon J; Kim J; Lee MS
    Ophthalmic Surg Lasers; 2000; 31(2):100-6. PubMed ID: 10743919
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Success rate and complications of intraoperative 0.2 mg/ml mitomycin C in trabeculectomy surgery.
    Singh J; O'Brien C; Chawla HB
    Eye (Lond); 1995; 9 ( Pt 4)():460-6. PubMed ID: 7498567
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Glaucoma drainage implants in Asian eyes.
    Aung T; Seah SK
    Ophthalmology; 1998 Nov; 105(11):2117-22. PubMed ID: 9818615
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Long-term filtration and visual field outcomes after primary glaucoma triple procedure with and without mitomycin-C.
    Shin DH; Iskander NG; Ahee JA; Singal IP; Kim C; Hughes BA; Eliassi-Rad B; Kim YY
    Ophthalmology; 2002 Sep; 109(9):1607-11. PubMed ID: 12208706
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Superior versus inferior Ahmed glaucoma valve implantation.
    Pakravan M; Yazdani S; Shahabi C; Yaseri M
    Ophthalmology; 2009 Feb; 116(2):208-13. PubMed ID: 19062098
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Trabeculectomy with mitomycin C in glaucoma associated with uveitis.
    Prata JA; Neves RA; Minckler DS; Mermoud A; Heuer DK
    Ophthalmic Surg; 1994; 25(9):616-20. PubMed ID: 7831006
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Efficacy of the Ahmed S2 glaucoma valve compared with the Baerveldt 250-mm2 glaucoma implant.
    Goulet RJ; Phan AD; Cantor LB; WuDunn D
    Ophthalmology; 2008 Jul; 115(7):1141-7. PubMed ID: 18164068
    [TBL] [Abstract][Full Text] [Related]  

  • 76. [Molteno/von Denffer drainage implants in therapy-refractory glaucomas].
    Jähne M; Sulzer G
    Klin Monbl Augenheilkd; 2005 Oct; 222(10):827-31. PubMed ID: 16240278
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Effects of postoperative mitomycin C eyedrop on trabeculectomy in refractory glaucoma patients.
    Choi MY; Hyung SM
    Korean J Ophthalmol; 1996 Jun; 10(1):34-41. PubMed ID: 8755200
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Molteno implantation for glaucoma in young patients.
    Hill RA; Heuer DK; Baerveldt G; Minckler DS; Martone JF
    Ophthalmology; 1991 Jul; 98(7):1042-6. PubMed ID: 1891211
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Postoperative 5-fluorouracil versus intraoperative mitomycin C in high-risk glaucoma filtering surgery: extended follow up.
    Akarsu C; Onol M; Hasanreisoglu B
    Clin Exp Ophthalmol; 2003 Jun; 31(3):199-205. PubMed ID: 12786769
    [TBL] [Abstract][Full Text] [Related]  

  • 80. A placebo-controlled, double-masked evaluation of mitomycin C in combined glaucoma and cataract procedures.
    Cohen JS; Greff LJ; Novack GD; Wind BE
    Ophthalmology; 1996 Nov; 103(11):1934-42. PubMed ID: 8942892
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.